Claro Advisors LLC Makes New Investment in CME Group Inc. (NASDAQ:CME)

Claro Advisors LLC acquired a new position in shares of CME Group Inc. (NASDAQ:CME) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,035 shares of the financial services provider’s stock, valued at approximately $670,000.

Other large investors have also recently added to or reduced their stakes in the company. Capital International Investors grew its stake in shares of CME Group by 24.1% during the first quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock valued at $3,403,557,000 after purchasing an additional 3,069,806 shares during the last quarter. PineStone Asset Management Inc. lifted its holdings in CME Group by 137.6% in the second quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider’s stock valued at $444,443,000 after buying an additional 1,309,097 shares during the period. Assenagon Asset Management S.A. lifted its holdings in CME Group by 577.9% in the second quarter. Assenagon Asset Management S.A. now owns 645,330 shares of the financial services provider’s stock valued at $126,872,000 after buying an additional 550,133 shares during the period. Ameriprise Financial Inc. lifted its holdings in CME Group by 11.3% in the second quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock valued at $1,038,676,000 after buying an additional 537,758 shares during the period. Finally, International Assets Investment Management LLC lifted its holdings in CME Group by 21,465.5% in the third quarter. International Assets Investment Management LLC now owns 485,871 shares of the financial services provider’s stock valued at $1,072,070,000 after buying an additional 483,618 shares during the period. 87.75% of the stock is owned by institutional investors.

CME Group Trading Up 0.8 %

Shares of NASDAQ:CME opened at $225.28 on Monday. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $230.36. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. The company’s fifty day simple moving average is $222.62 and its 200 day simple moving average is $210.39. The firm has a market cap of $81.18 billion, a price-to-earnings ratio of 23.69, a PEG ratio of 5.20 and a beta of 0.55.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The firm’s revenue for the quarter was up 18.4% compared to the same quarter last year. During the same quarter last year, the firm earned $2.25 earnings per share. As a group, research analysts forecast that CME Group Inc. will post 10.22 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be given a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a yield of 2.04%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s dividend payout ratio (DPR) is currently 48.37%.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on CME shares. Barclays increased their price objective on shares of CME Group from $219.00 to $231.00 and gave the company an “equal weight” rating in a report on Thursday, October 24th. Citigroup increased their price objective on shares of CME Group from $250.00 to $255.00 and gave the company a “buy” rating in a report on Thursday, October 24th. Redburn Atlantic lowered shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price objective on the stock. in a report on Tuesday, October 8th. Piper Sandler increased their target price on shares of CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a report on Monday, October 28th. Finally, Morgan Stanley increased their target price on shares of CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a report on Thursday, October 17th. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, CME Group has an average rating of “Hold” and an average price target of $224.47.

Insider Activity at CME Group

In related news, insider Sunil Cutinho sold 4,500 shares of CME Group stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $226.64, for a total transaction of $1,019,880.00. Following the completion of the transaction, the insider now owns 27,053 shares in the company, valued at approximately $6,131,291.92. This trade represents a 14.26 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Timothy Francis Mccourt sold 1,374 shares of the business’s stock in a transaction that occurred on Monday, October 28th. The stock was sold at an average price of $227.12, for a total value of $312,062.88. Following the transaction, the insider now directly owns 7,275 shares in the company, valued at approximately $1,652,298. This trade represents a 15.89 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 15,621 shares of company stock valued at $3,441,063. Corporate insiders own 0.30% of the company’s stock.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.